Epstein-Barr virus infection associated hepatic lymphoma in a patient treated with methotrexate for rheumatoid arthritis.
Martin
M
Soubrier
Stéphanie
S
Arrestier
Sarah
S
Bouloudian
Jean-Jacques
JJ
Dubost
Jean-Michel
JM
Ristori
D018501:Antirheumatic Agents / Q000276:immunology / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy* / Q000276:immunology; D018572:Disease-Free Survival; D020031:Epstein-Barr Virus Infections / Q000150:complications* / Q000276:immunology / Q000473:pathology; D005260:Female; D004854:Herpesvirus 4, Human / Q000302:isolation & purification* / Q000502:physiology; D006801:Humans; D016867:Immunocompromised Host; D008113:Liver Neoplasms / Q000276:immunology / Q000473:pathology / Q000821:virology*; D016393:Lymphoma, B-Cell / Q000276:immunology / Q000473:pathology / Q000821:virology*; D008727:Methotrexate / Q000276:immunology / Q000627:therapeutic use*; D008875:Middle Aged; D028761:Withholding Treatment
D018501:Antirheumatic Agents; D008727:Methotrexate